Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of August 19, 2026, ERNA trades at $4.48 with a market cap of $4.74M and a P/E ratio of -1.94. ERNA moved +5.32% today. Year to date, ERNA is -85.83%; over the trailing twelve months it is -89.44%. Its 52-week range spans $3.18 to $360.00. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ERNA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.48 |
| Market Cap | $4.74M |
| P/E Ratio | -1.94 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $360.00 |
| 52-Week Low | $3.18 |
| Volume | 71 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.08M |
| Gross Margin | 0.00% |
ERNA analyst coverage data. Average price target: $0.00.